Pharmacists in Cullman, AL Accepting Medicare
66 Pharmacists found. Showing 61 - 66
 Dr. Courtney Weber, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1606 2nd Ave Sw, Cullman, AL 35055 Phone: 125-673-9199 |
 Dr. Christopher Todd Mcannally, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 2nd Ave Sw, Cullman, AL 35055 Phone: 256-734-7188 |
Janine Tv Lee, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1906 Cherokee Ave Sw, Cullman, AL 35055 Phone: 256-775-8778 Fax: 256-775-8783 |
Tori Ellen Swann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1104 Cullman Shopping Ctr Nw, Cullman, AL 35055 Phone: 256-736-7005 |
Sonya Peters Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1912 Al Highway 157, Cullman, AL 35058 Phone: 256-737-2000 |
Dr. Mandy Lynne Calvert, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 2nd Ave Sw, Cullman, AL 35055 Phone: 256-734-7188 |
News Archive
How dementia spreads: new study says it's through neural networks
Scientists have found out a way to forecast the spread of brain atrophy, using prior research that shows how brain networks connect with each other to form a continuously linked pathway.
Synthetic oral cannabinoid use found to be more common among older adults with COPD
A study published today in Drugs & Aging found that older adults in Ontario with chronic obstructive pulmonary disease were twice as likely to use prescription synthetic oral cannabinoids compared to older adults without COPD.
Study finds little evidence of 'immigrant health paradox' among Arab Americans
First generation immigrants to the United States from Latin America, South America, and Asia have been shown to have better health outcomes and behaviors than second generation (born in the U.S. to immigrant parents) and third generation (born in the U.S. to U.S.-born parents with immigrant heritage) immigrants - a phenomenon known as the "immigrant health paradox."
Key scientific work in Cardio3 BioSciences' C-Cure stem cell heart failure treatment published in JACC
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in regenerative therapies for the treatment of cardiovascular disease, today announces that the key scientific work underlying its lead pharmaceutical product C-Cure(R), a revolutionary stem cell treatment for heart failure, has been published in the Journal of the American College of Cardiology (JACC). The findings were described as "landmark work" in the accompanying editorial in today's publication.
› Verified 8 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Occupational Therapists